(Q36257275)

13 August 2017

0 references

Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: meta-analysis of clinical studies (English)

1 reference

13 August 2017

1 reference

1

Fabrizio Fabrizi

1 reference

13 August 2017

5

Fasiha Kanwal

1 reference

13 August 2017

Paul Martin

2

1 reference

13 August 2017

Vivek Dixit

series ordinal

3

1 reference

13 August 2017

Suphamai Bunnapradist

series ordinal

4

1 reference

13 August 2017

Gareth Dulai

series ordinal

6

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

American Journal of Transplantation

13 August 2017

published in

1 reference

13 August 2017

volume

5

1 reference

13 August 2017

issue

10

1 reference

13 August 2017

page(s)

2433-2440

1 reference

Management of chronic viral hepatitis before and after renal transplantation

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Hepatitis C virus infection and de novo glomerular lesions in renal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Pretransplant hepatitis C virus infection: a predictor of proteinuria after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Association of diabetes mellitus and chronic hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Post-liver transplantation diabetes mellitus: an association with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Outcome of hepatitis C virus-infected kidney transplant candidates who remain on the waiting list

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

The retrieval of randomized clinical trials in liver disease from the medical literature. A comparison of MEDLARS and manual methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Association between hepatitis C virus infection and development of posttransplantation diabetes mellitus in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Hepatitis C and the incidence of diabetes mellitus after renal transplant: influence of new immunosuppression protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Is hepatitis C a risk factor to posttransplant diabetes mellitus after renal transplantation in patients using tacrolimus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Risk factors and incidence of posttransplant diabetes mellitus in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Development of diabetes mellitus following kidney transplantation: a Canadian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Posttransplant diabetes mellitus in renal transplant patients with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Diabetes mellitus after kidney transplantation in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Impact of diabetes and hepatitis after kidney transplantation on patients who are affected by hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Tacrolimus-associated posttransplant diabetes mellitus in renal transplant recipients: role of hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

The importance of quality of primary studies in producing unbiased systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Insulin resistance and insulin secretion in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: specific detection of negative-strand viral RNA in various tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01040.X

10.1111/J.1600-6143.2005.01040.X

21 January 2018

Identifiers

DOI

1 reference

release_n24w5hwaqvaeth7ychajw4c5cy

13 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/n24w5hwaqvaeth7ychajw4c5cy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference